Among them, CDC25A and SLC1A5 displayed protective effects against STAD, while the rest genes (ATF3, CAV1, CP, DDR2, GPX3, JAM3, ZFP36, NOX4, and SPARC) were prognostic risk genes for STAD. Here, SPARC is linked to gastric adenocarcinoma.